- Home
- TNFA vs TCRT Comparison
TNFA vs TCRT Comparison
Compare TNFA & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNFA
- TCRT
- Stock Information
- Founded
- TNFA 2014
- TCRT 1998
- Country
- TNFA United States
- TCRT United States
- Employees
- TNFA N/A
- TCRT N/A
- Industry
- TNFA
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- TNFA
- TCRT Health Care
- Exchange
- TNFA NYSE
- TCRT Nasdaq
- Market Cap
- TNFA 3.7M
- TCRT 3.8M
- IPO Year
- TNFA N/A
- TCRT N/A
- Fundamental
- Price
- TNFA $1.20
- TCRT $2.08
- Analyst Decision
- TNFA
- TCRT
- Analyst Count
- TNFA 0
- TCRT 0
- Target Price
- TNFA N/A
- TCRT N/A
- AVG Volume (30 Days)
- TNFA 27.7K
- TCRT 14.2K
- Earning Date
- TNFA 11-29-2024
- TCRT 11-14-2024
- Dividend Yield
- TNFA N/A
- TCRT N/A
- EPS Growth
- TNFA N/A
- TCRT N/A
- EPS
- TNFA N/A
- TCRT N/A
- Revenue
- TNFA N/A
- TCRT $7,000.00
- Revenue This Year
- TNFA N/A
- TCRT N/A
- Revenue Next Year
- TNFA N/A
- TCRT N/A
- P/E Ratio
- TNFA N/A
- TCRT N/A
- Revenue Growth
- TNFA N/A
- TCRT N/A
- 52 Week Low
- TNFA $1.15
- TCRT $1.95
- 52 Week High
- TNFA $10.68
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- TNFA 36.11
- TCRT 44.32
- Support Level
- TNFA $1.26
- TCRT $2.00
- Resistance Level
- TNFA $1.44
- TCRT $2.86
- Average True Range (ATR)
- TNFA 0.13
- TCRT 0.17
- MACD
- TNFA -0.02
- TCRT 0.05
- Stochastic Oscillator
- TNFA 7.69
- TCRT 14.29
About TNFA TNF PHARMACEUTICALS INC EFFEC
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.